Molecular Glue Labs
Developing AI-powered solutions for drug discovery.
About
Molecular Glue Labs is a UK-based AI startup focused on solving concrete, high-impact problems in the life sciences sector, specifically in drug discovery. They leverage domain expertise and AI to accelerate the development of new therapeutics.
Similar companies
Computational platform using LLMs trained on biological and chemical data for drug discovery.
Shares Life Sciences, Drug Discovery
Genocure AI is developing AI-powered solutions for oncology drug discovery and development.
Shares Life Sciences, Biotech
AI-powered antibody discovery platform.
Shares Biotechnology, Artificial Intelligence
BioCorteX is a tech bio company developing precision medicine solutions using AI-powered in-silico simulations to understand drug-bacteria interactions and personalize treatments.
Shares Artificial Intelligence, Biotech
AI-powered drug discovery platform for accelerated molecular design.
Shares Biotech, Drug Discovery
Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Shares Biotechnology, Life Sciences
Key facts
- Headquarters
- United Kingdom
- Founded
- 2024
- Total funding
- $5M (Seed)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 3 Apr 2024 | Seed | $5M |
Frequently asked
How much funding has Molecular Glue Labs raised?
Molecular Glue Labs has raised a total of $5M in funding. The most recent round on record is Seed.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Molecular Glue Labs
